There are new concerns about what was thought to be a promising vaccine against the deadly Ebola virus.
During the outbreak in West Africa, a new vaccine was developed by Merck and New Link Genetics.
[Ads /]
A report in December said the vaccine was 100% effective.
But now, experts are questioning the way the study results were interpreted.
They say the vaccine provides some protection, but, in reality, that protection could be low.
----------
[Ads /]
Send a breaking news alert
Report a correction or typo
Learn more about the 6abc apps
